LncRNA RHPN1-AS1 Serves As a Sponge for MiR-3133 Modulating the Cell Proliferation of Retinoblastoma Through JAK2
Overview
Biotechnology
General Medicine
Affiliations
Purpose: To investigate the effects of lncRNA RHPN1-AS1 on retinoblastoma (RB) and further explore its underlying molecular mechanisms.
Methods: The expression of RHPN1-AS1, miR-3133, (JAK2), and signal transducer and activator of transcription 3 (STAT3) was detected by qRT-PCR. CCK-8, EDU, and flow cytometry assays were conducted to assess the proliferation activity and apoptosis of RB cells. Double fluorescein and RNA immunoprecipitation assays were performed to detect the interaction between RHPN1-AS1 and miR-3133 or miR-3133 and JAK2. Western blotting was performed to detect the expression of apoptosis-related proteins.
Results: In RB cells, RHPN1-AS1 was upregulated. Silencing RHPN1-AS1 inhibited the activity of RB cells and promoted apoptosis. The expressions of proapoptotic factors (Bax and p53) were increased, while antiapoptotic factors (Bcl-2 and Survivin) were suppressed in siRHPN1-AS1 groups. Furthermore, we predicted and verified that RHPN1-AS1 regulated RB progression by targeting miR-3133/JAK2. In addition, siRHPN1-AS1 also inhibited oncogene STAT3 protein expression.
Conclusion: lncRNA RHPN1-AS1 served as a sponge for miR-3133 to counteract miR-3133-mediated JAK2/STAT3 suppression, indicating that the lncRNA RHPN1-AS1 may be a potential therapeutic target for the treatment of RB.
Zhou L, Guo H, Liao Q, Zou J, Le Y, Fang Z J Cell Mol Med. 2023; 27(20):3090-3106.
PMID: 37555915 PMC: 10568676. DOI: 10.1111/jcmm.17880.
miR-3133 is an unfavorable prognosis factor and tumor suppressor in colon cancer.
Gao H, Zhang C Funct Integr Genomics. 2023; 23(2):132.
PMID: 37079151 DOI: 10.1007/s10142-023-01059-3.
Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.
Ahangar Davoodi N, Najafi S, Ghale-Noie Z, Piranviseh A, Mollazadeh S, Ahmadi Asouri S Front Cell Dev Biol. 2023; 10:1065837.
PMID: 36619866 PMC: 9816416. DOI: 10.3389/fcell.2022.1065837.